Heart Test Laboratories Inc. (NASDAQ:HSCS) has a beta value of 3.16 and has seen 12.06 million shares traded in the recent trading session. The company, currently valued at $3.83M, closed the recent trade at $4.21 per share which meant it gained $1.27 on the day or 43.20% during that session. The HSCS stock price is -1135.15% off its 52-week high price of $52.00 and 43.94% above the 52-week low of $2.36. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.27 million shares traded. The 3-month trading volume is 101.31K shares.
The consensus among analysts is that Heart Test Laboratories Inc. (HSCS) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Heart Test Laboratories Inc. (NASDAQ:HSCS) trade information
Sporting 43.20% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the HSCS stock price touched $4.21 or saw a rise of 8.48%. Year-to-date, Heart Test Laboratories Inc. shares have moved -75.38%, while the 5-day performance has seen it change 46.18%. Over the past 30 days, the shares of Heart Test Laboratories Inc. (NASDAQ:HSCS) have changed 13.17%. Short interest in the company has seen 39699.0 shares shorted with days to cover at 1.97.
Wall Street analysts have a consensus price target for the stock at $3, which means that the shares’ value could drop -40.33% from the levels at last check today. The projected low price target is $3.0 while the price target rests at a high of $3.0. In that case, then, we find that the latest price level in today’s session is 28.74% off the targeted high while a plunge would see the stock lose 28.74% from the levels at last check today.
Heart Test Laboratories Inc. (HSCS) estimates and forecasts
The company’s shares have lost -64.92% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 20.70% over the past 5 years.
HSCS Dividends
Heart Test Laboratories Inc. is expected to release its next earnings report on 2024-Sep-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Heart Test Laboratories Inc. (NASDAQ:HSCS)’s Major holders
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. As of Jul 31, 2024, the former fund manager holds about 0.31% shares in the company for having 2.86 shares of worth $12158.0 while later fund manager owns 1.92 shares of worth $8142.0 as of Jun 30, 2024, which makes it owner of about 0.21% of company’s outstanding stock.
